HIV News and Research

RSS

Researchers gain better understanding of HIV infection through electron microscopy

The human intestinal tract, or gut, is best known for its role in digestion. But this collection of organs also plays a prominent role in the immune system. In fact, it is one of the first parts of the body that is attacked in the early stages of an HIV infection. Knowing how the virus infects cells and accumulates in this area is critical to developing new therapies for the over 33 million people worldwide living with HIV. Researchers at the California Institute of Technology are the first to have utilized high-resolution electron microscopy to look at HIV infection within the actual tissue of an infected organism, providing perhaps the most detailed characterization yet of HIV infection in the gut.

30 Jan 2014

Geranium plant extracts prevent HIV-1 from invading human cells

Extracts of the geranium plant Pelargonium sidoides inactivate human immunodeficiency virus type 1 (HIV-1) and prevent the virus from invading human cells. In the current issue of "PLOS ONE", scientists from the Helmholtz Zentrum München report that these extracts represent a potential new class of anti-HIV-1 agents for the treatment of AIDS.

30 Jan 2014

Researcher to study how to address shortage of mental health services in Vietnam

A Simon Fraser University researcher is going to Vietnam to study how to address the shortage of accessible and adequate services for people with mental disorders like depression and anxiety.

30 Jan 2014

EGPAF donates medical equipment to Swaziland to improve health of mothers and children

The Elizabeth Glaser Pediatric AIDS Foundation in collaboration with Project C.U.R.E (Commission on Urgent Relief and Equipment) today donated medical equipment and supplies worth more than U.S. $500,000 to the Government of the Kingdom of Swaziland's Ministry of Health to help strengthen health services provided to mothers, infants, and children in the country.

30 Jan 2014

CONRAD receives USAID Pioneers Prize for developing tenofovir gel to reduce HIV infection in women

CONRAD, a leading reproductive health-research organization based at Eastern Virginia Medical School (EVMS), today announced that they are a winner of the United States Agency for International Development (USAID) Science and Technology Pioneers Prize for their work in developing tenofovir gel.

29 Jan 2014

Global atlas identifies greatest need for palliative care in low-and middle-income countries

Only 1 in 10 people who need palliative care - that is medical care to relieve the pain, symptoms and stress of serious illness - is currently receiving it. This unmet need is mapped for the first time in the "Global atlas of palliative care at the end of life", published jointly by the WHO and the Worldwide Palliative Care Alliance.

29 Jan 2014

Researchers identify unique area of human brain associated with cognitive powers

Oxford University researchers have identified an area of the human brain that appears unlike anything in the brains of some of our closest relatives.

29 Jan 2014

Biologists identify protein targets for next-generation of anti-HIV drugs

People infected with the Human Immunodeficiency Virus (HIV) can stave off the symptoms of AIDS thanks to drug cocktails that mainly target three enzymes produced by the virus, but resistant strains pop up periodically that threaten to thwart these drug combos.

29 Jan 2014

Researchers create vaginal cream using silver nanoparticles to control transmition of HIV

The product has proven efficiency in lab tests, although clinical trials are yet to be performed. After discovering that silver nanoparticles are capable of blocking the entry of Human Immunodeficiency Virus (HIV) into the organism, a group of researchers from the University of Texas, in collaboration with Humberto Lara Villegas, specialist in nanoparticles and virology from the University of Monterrey, Mexico (UDEM), create a vaginal cream to control the transmition of the virus.

28 Jan 2014

State highlights: N.Y. revises its request for Medicaid adjustment; transplant waiting periods for new coverage in Wash.

A selection of health policy stories from New York, Washington state, California, Virginia, Idaho, Connecticut and Georgia.

28 Jan 2014

Patients' race or ethnicity linked with differences in prescription of HIV drug

A lot of evidence shows that a patients' race or ethnicity is associated with differences in how health care providers communicate with them, the health care they receive, and their health outcomes.

28 Jan 2014

First Edition: January 27, 2014

Today's headlines include a report about a new Associated Press poll that found some negative views of the health law may be easing.

27 Jan 2014

UTSA and Health Science Center receive grant to prevent substance abuse, HIV/AIDS transmission among young adults

The UTSA Institute for Health Disparities Research in the College of Liberal and Fine Arts and The University of Texas Health Science Center at San Antonio Division of Community Pediatrics have been awarded $900,000 in funding from the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Prevention (CSAP) for a collaborative project between a Minority-Serving Institution and Community-Based Organization(s) to prevent and reduce Substance Abuse (SA) and HIV/AIDS transmission among young adults.

24 Jan 2014

Mylan Pharmaceuticals launches Repaglinide Tablets, 0.5 mg, 1 mg and 2 mg

Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Repaglinide Tablets, 0.5 mg, 1 mg and 2 mg. This product is the generic version of Novo Nordisk's Prandin, which is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

24 Jan 2014

CytRx initiates aldoxorubicin Phase 2 trial in HIV-infected patients with Kaposi's sarcoma

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a Phase 2 clinical trial to determine preliminary efficacy and safety of aldoxorubicin for HIV-infected patients with Kaposi's sarcoma.

23 Jan 2014

Inovio Pharmaceuticals unveils new DNA-based cytokine immune activator

Inovio Pharmaceuticals, Inc. today unveiled that the company has developed a new DNA-based cytokine immune activator, interleukin -33 (IL-33), that in combination with optimized DNA vaccines delivered by electroporation increased the potency and efficacy of the therapeutic response to the DNA vaccines in a preclinical study.

23 Jan 2014

CWRU researchers receive NIAID grant to conduct HIV research and clinical trials

AIDS researchers from Case Western Reserve University and University Hospitals Case Medical Center have received a seven-year funding award from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

23 Jan 2014

Researchers find definitive link between intimate partner violence and HIV risk

Researchers from The Miriam Hospital and the University of Rochester have found a definitive link between violence among intimate partners and an increased risk of HIV infection. The study is online in the journal Women & Health.

23 Jan 2014

New community program helps African-American women embrace good health, reduce HIV risk

A new community program is helping African-American women embrace good health by enabling treatment of substance abuse and mental health problems that increase their risk of HIV infection or spreading the virus.

22 Jan 2014

Xpert MTB/RIF test quickly detects TB and resistance to rifampicin

A second systematic review of a diagnostic test for tuberculosis (TB) endorsed by the World Health Organisation (WHO), has confirmed the accuracy of the test. The updated review assessing the accuracy of Xpert MTB/RIF includes new studies published since the original Cochrane Review was published in January last year.

22 Jan 2014

HIV News and Research

Researchers gain better understanding of HIV infection through electron microscopy

Geranium plant extracts prevent HIV-1 from invading human cells

Researcher to study how to address shortage of mental health services in Vietnam

EGPAF donates medical equipment to Swaziland to improve health of mothers and children

CONRAD receives USAID Pioneers Prize for developing tenofovir gel to reduce HIV infection in women

Global atlas identifies greatest need for palliative care in low-and middle-income countries

Researchers identify unique area of human brain associated with cognitive powers

Biologists identify protein targets for next-generation of anti-HIV drugs

Researchers create vaginal cream using silver nanoparticles to control transmition of HIV

State highlights: N.Y. revises its request for Medicaid adjustment; transplant waiting periods for new coverage in Wash.

Patients' race or ethnicity linked with differences in prescription of HIV drug

First Edition: January 27, 2014

UTSA and Health Science Center receive grant to prevent substance abuse, HIV/AIDS transmission among young adults

Mylan Pharmaceuticals launches Repaglinide Tablets, 0.5 mg, 1 mg and 2 mg

CytRx initiates aldoxorubicin Phase 2 trial in HIV-infected patients with Kaposi's sarcoma

Inovio Pharmaceuticals unveils new DNA-based cytokine immune activator

CWRU researchers receive NIAID grant to conduct HIV research and clinical trials

Researchers find definitive link between intimate partner violence and HIV risk

New community program helps African-American women embrace good health, reduce HIV risk

Xpert MTB/RIF test quickly detects TB and resistance to rifampicin

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News